Concepedia
Statistics
Publications
33
Citations
1.7K
H-Index
24
Active since
2006
Affiliations
Brigham and Women's Hospital(Current)
Harvard University
University of Waterloo
University of Arizona
Dana-Farber Cancer Institute
Aaron Goldman is an author at Brigham and Women's Hospital specializing in oncology, medicine, and molecular oncology.
Publications per year
2006–2023
Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition
Aaron Goldman, Biswanath Majumder, Andrew Dhawan et al. · Nature Communications · 2015 · 286 citations · Full text
Medicine, Oncology, Pharmacology +16
Notch-Jagged signalling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype
Marcelo Boareto, Mohit Kumar Jolly, Aaron Goldman et al. · Journal of The Royal Society Interface · 2016 · 148 citations · Full text
Life Sciences, Cell Biology, Oncology +17
NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells
Wucheng Qi, Kishore Shakalya, A Stejskal et al. · Oncogene · 2008 · 121 citations
Life Sciences, Molecular Biology, Oncology +10
Reporter nanoparticle that monitors its anticancer efficacy in real time
Ashish Kulkarni, Poornima Rao, Siva Kumar Natarajan et al. · Proceedings of the National Academy of Sciences · 2016 · 77 citations · Full text
Medicine, Cancer Biology, Oncology +17
Role of cyclophilin D in the resistance of brain mitochondria to the permeability transition
Roman A. Eliseev, Gleb Filippov, Janice Velos et al. · Neurobiology of Aging · 2006 · 76 citations
Life Sciences, Biochemistry, Neuroscience +16
1–5 of 33